These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15073599)

  • 21. High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma.
    Carr-Wilkinson J; O'Toole K; Wood KM; Challen CC; Baker AG; Board JR; Evans L; Cole M; Cheung NK; Boos J; Köhler G; Leuschner I; Pearson AD; Lunec J; Tweddle DA
    Clin Cancer Res; 2010 Feb; 16(4):1108-18. PubMed ID: 20145180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wip1 over-expression correlated with TP53/p14(ARF) pathway disruption in human astrocytomas.
    Wang P; Rao J; Yang H; Zhao H; Yang L
    J Surg Oncol; 2011 Nov; 104(6):679-84. PubMed ID: 21695702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P53 overexpression and proliferative potential in malignant meningiomas.
    Nagashima G; Aoyagi M; Yamamoto M; Yamamoto S; Wakimoto H; Ohno K; Yamamoto K; Hirakawa K
    Acta Neurochir (Wien); 1999; 141(1):53-61; discussion 60-1. PubMed ID: 10071687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The determination of stage in nonmuscle urothelial carcinoma: Staining pattern of caspase-8.
    Türk NŞ; Eskiçorapçi S; Aybek Z; Tuncay L
    Indian J Pathol Microbiol; 2018; 61(2):192-196. PubMed ID: 29676355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors.
    Eymin B; Gazzeri S; Brambilla C; Brambilla E
    Oncogene; 2002 Apr; 21(17):2750-61. PubMed ID: 11965548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status.
    Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D
    Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas.
    Cho H; Ha SY; Park SH; Park K; Chae YS
    J Korean Med Sci; 1999 Apr; 14(2):199-205. PubMed ID: 10331568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse.
    Carr J; Bell E; Pearson AD; Kees UR; Beris H; Lunec J; Tweddle DA
    Cancer Res; 2006 Feb; 66(4):2138-45. PubMed ID: 16489014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
    Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
    Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
    Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma.
    Mori S; Ito G; Usami N; Yoshioka H; Ueda Y; Kodama Y; Takahashi M; Fong KM; Shimokata K; Sekido Y
    Cancer; 2004 Apr; 100(8):1673-82. PubMed ID: 15073856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
    Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
    Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver.
    Weihrauch M; Markwarth A; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A
    Hum Pathol; 2002 Sep; 33(9):884-92. PubMed ID: 12378512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
    Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G
    EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p14(ARF) regulates E2F activity.
    Mason SL; Loughran O; La Thangue NB
    Oncogene; 2002 Jun; 21(27):4220-30. PubMed ID: 12082609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells.
    Takemoto S; Trovato R; Cereseto A; Nicot C; Kislyakova T; Casareto L; Waldmann T; Torelli G; Franchini G
    Blood; 2000 Jun; 95(12):3939-44. PubMed ID: 10845931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and methylation status of CDKN2A (p14
    Chantre-Justino M; Gonçalves da Veiga Pires I; Cardoso Figueiredo M; Dos Santos Moreira A; Alves G; Faria Ornellas MH
    Hum Pathol; 2022 Jan; 119():94-104. PubMed ID: 34826422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas.
    Karamitopoulou E; Perentes E; Tolnay M; Probst A
    Hum Pathol; 1998 Feb; 29(2):140-5. PubMed ID: 9490273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of the p16(INK4) locus in human malignant mesothelial tumors.
    Hirao T; Bueno R; Chen CJ; Gordon GJ; Heilig E; Kelsey KT
    Carcinogenesis; 2002 Jul; 23(7):1127-30. PubMed ID: 12117769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.